期刊文献+

多发性骨髓瘤67例生存期及影响因素分析 被引量:4

Survival time and correlation factors of multiple myeloma——a report of 67 cases
原文传递
导出
摘要 目的多发性骨髓瘤(MM)是一种异质性的浆细胞肿瘤,预后不良。本研究旨在探讨MM患者的预后因素和临床适用的分期。方法收集1998年12月至2010年5月67例确诊MM患者的临床和实验室指标,并将患者分别按照Bataille分期、Durie-Salmon(DS)分期和国际分期系统(ISS)分期法进行分期,进行Log-rank检验单因素分析和COX回归模型多因素分析,评价MM预后因素,比较三种分期法的生存情况。结果 67例患者男41例,女26例,中位年龄62岁,中位生存期33个月,2年生存率74.1%,5年生存率25.6%。单因素分析结果提示年龄、骨髓浆细胞总数、白蛋白、血清β2微球蛋白(β2-MG)、肌酐、乳酸脱氢酶、血钙、尿酸与预后相关,多因素分析显示β2-MG、白蛋白、肌酐和年龄为独立预后因素。DS分期中三期间生存期存在显著差异,ISS分期和Bataille分期中,Ⅱ期和Ⅲ期的生存期存在统计学差异,而Ⅰ期和Ⅱ期的生存期无统计学差异。结论 MM患者高β2-MG、低白蛋白、高肌酐、高龄者预后较差。DS分期对我国患者比较适合。 Objective Multiple myeloma(MM) is a heterogeneous disease of plasma cell tumor with poor prognosis.This study was to analysis the prognostic factors of MM in China,and find the most suitable clinical staging systems.Methods Univariate and multivariate analyses were carried out on clinical and laboratory indexes from 67 MM patients,which were recruited from December 1998 to May 2010.These MM patients were classified according to Durie Salmon staging system,International staging system and Bataille staging system.The prognosis factors were analyzed by Log-Rank test and COX regression model,and the survival rates of 3 staging systems were compared.Results Among the 67 patients,41 were men and 26 were women,with median age of 62 years and median survival time of 33 months.The 2 and 5 year survival rates were 74.1% and 25.6%.Univariate analysis identified 8 prognostic factors:age,the amount of the bone marrow plasma cells,serum albumin,serum beta2-microglobulin(β2-MG),creatinine,lactate dehydrogenase,serum calcium and serum uric acid.Multivariate analysis showed that β2-MG,albumin,creatinine and age were independent prognostic factors.Significant differences of survival period existed among the 3 groups classified according to Durie Salmon staging system as well as between group Ⅱand group Ⅲ of International staging system and Bataille staging system.However,no significant difference was found between group Ⅰand group Ⅱ of International staging system and Bataille staging system.Conclusions High level of β2-MG,low level of albumin,high level of creatinine and old age are correlated to poor prognosis.Durie Salmon staging system is suitable for Chinese MM patients.
出处 《中华临床医师杂志(电子版)》 CAS 2011年第16期4761-4765,共5页 Chinese Journal of Clinicians(Electronic Edition)
关键词 多发性骨髓瘤 临床分期 生存期 预后 Multiple myeloma Clinical staging system Survival time Prognosis
  • 相关文献

参考文献16

  • 1关晶,付蓉,邵宗鸿,阮二宝,梁勇,瞿文,王国锦,王晓明,刘鸿,吴玉红,宋嘉,王化泉,邢莉民.多发性骨髓瘤存活期及影响因素研究[J].中国肺癌杂志,2009,12(6):655-655. 被引量:1
  • 2张媛,李大胜,屈辉.多发骨髓瘤与多发骨转移瘤的鉴别诊断[J].中华临床医师杂志(电子版),2007,1(6):53-55. 被引量:7
  • 3李红梅,敬华,侯健,仲人前,戚春建,孔宪涛,张学光.多发性骨髓瘤患者血清乳酸脱氢酶水平与病程及预后关系的分析[J].中华血液学杂志,2004,25(10):625-626. 被引量:9
  • 4苏畅,罗绍凯,许丽梅,颜棉生.轻链型多发性骨髓瘤23例临床分析[J].中国全科医学,2004,7(18):1308-1309. 被引量:20
  • 5Jeong Eun Kim,Changhoon Yoo,Dae Ho Lee,Sang-We Kim,Jung-Shin Lee,Cheolwon Suh.Serum albumin level is a significant prognostic factor reflecting disease severity in symptomatic multiple myeloma[J]. Annals of Hematology . 2010 (4)
  • 6Krejci M,Hajek R,Buchler T,et al.Simple variables predict survival after autologous transplantation:a single centre experience in181multile my-eloma patients. Neoplasma . 2007
  • 7Barlogie B,Bolejack V,Schell M,et al.Prognostic factor analyses of myeloma survival with intergroup trial S9321(INT0141):examining whether different variables govern different time segments of survival. Annals of Hematology . 2011
  • 8Dimopoulos MA,Terpos E,Chanan-Khan A,et al.Renal Impairment in Patients With Multiple Myeloma:A Consensus Statement on Behalf of the International Myeloma Working Group. Journal of Clinical Oncology . 2010
  • 9Eleutherakis-Papaiakovou V,Bamias A,Gika D,et al.Renal failure in multiple myeloma:incidence,correlations,and prognostic significance. Leukemia and Lymphoma . 2007
  • 10D Clerc,JP Fermand,X Mariette.Treatment of multiple myeloma. Joint Bone Spine . 2003

二级参考文献10

  • 1Durie BGM,Salmon SE.A clinical staging system for multiple myeloma[J].Cancer,1975,36:842-854.
  • 2Knudsen L M,Hippe E,Hjorth M,et al.Renal function in newly diagnosed multiple myeloma-a demographic study of 1353 patients.The Nordic Myeloma Study Group[J].Eur J Haematol,1994,53(4):207-212.
  • 3Gale RP,Park RE,Dubosi RW,et al.Delphi-Panel analysis of appropriatenese of high dose therapy and bone marrow autotransplants in newly diagnosed multiple myeloma.Leuk Lymphoma,1999,33:511-519.
  • 4Alexandrakis MG, Passam FH, Ganotakis ES, et al. The clinical and prognostic significance of erythrocyte sedimentation rate ( ESR), serum interleukin-6 (IL-6) and acute phase protein levels in multiple myeloma. Clin Lab Haematol, 2003, 25: 41-46.
  • 5Astrom M, Bodin L, Nilsson I, et al. Treatment long-term outcome and prognostic variable in 214 unselected AML patients in Sweden. Br J Cancer, 2000,82: 1387-1392.
  • 6Dawson ST. Long-term risk of malignant neoplasm associated with gestational glucose intolerance. Cancer, 2004,100: 149-155.
  • 7Velichko MG, Petushole VG, Gorbach ZV, et al. Lactate level in the tissues of animals with a tumor administered oxythiamine and the properties of lactate dehydrogenase. Vopr Med Khim, 1981,27: 594-600.
  • 8P. G. Koenders,L. V. A. M. Beex,R. Langens,P. W. C. Kloppenborg,A. G. H. Smals,Th. J. Benraad. Steroid hormone receptor activity of primary human breast cancer and pattern of first metastasis[J] 1991,Breast Cancer Research and Treatment(1):27~32
  • 9傅元芳,李启权,陈双,周全.多发性骨髓瘤与骨转移瘤的X线及CT鉴别诊断[J].暨南大学学报(自然科学与医学版),1999,20(4):112-116. 被引量:4
  • 10欧阳凰晴,章志霖,李茂进.中轴骨骨髓MR成像研究[J].临床放射学杂志,2002,21(10):799-803. 被引量:8

共引文献33

同被引文献39

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部